Gepotidacin Mesylate Patent Expiration

Gepotidacin Mesylate was first introduced by Glaxosmithkline Llc in its drug Blujepa on Mar 25, 2025.

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List